Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Interferon-kappa, a novel type I interferon expressed in human keratinocytes.

LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA.

J Biol Chem. 2001 Oct 26;276(43):39765-71. Epub 2001 Aug 20.

2.

Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice.

Vassileva G, Chen SC, Zeng M, Abbondanzo S, Jensen K, Gorman D, Baroudy BM, Jiang Y, Murgolo N, Lira SA.

J Immunol. 2003 Jun 1;170(11):5748-55.

3.

Inhibition of interferons by ectromelia virus.

Smith VP, Alcami A.

J Virol. 2002 Feb;76(3):1124-34.

4.
5.
6.

Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.

Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, Bachmann A, Ritter TM, Dondog B, Ly R, Bosch FX, Zawatzky R, Rösl F.

Cancer Res. 2009 Nov 15;69(22):8718-25. doi: 10.1158/0008-5472.CAN-09-0550. Epub 2009 Nov 3.

7.

Identification of novel genes for secreted and membrane-anchored proteins in human keratinocytes.

Bonkobara M, Das A, Takao J, Cruz PD, Ariizumi K.

Br J Dermatol. 2003 Apr;148(4):654-64.

PMID:
12752121
8.

The human interferon alpha/beta receptor: characterization and molecular cloning.

Novick D, Cohen B, Rubinstein M.

Cell. 1994 May 6;77(3):391-400.

PMID:
8181059
9.

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Zhu H, Butera M, Nelson DR, Liu C.

Virol J. 2005 Sep 7;2:80.

10.
11.

Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation.

Gamero AM, Sakamoto S, Montenegro J, Larner AC.

J Biol Chem. 2004 Mar 26;279(13):12379-85. Epub 2004 Jan 13.

12.

Interferon-delta: the first member of a novel type I interferon family.

Lefèvre F, Guillomot M, D'Andréa S, Battegay S, La Bonnardière C.

Biochimie. 1998 Aug-Sep;80(8-9):779-88. Review.

PMID:
9865499
13.

Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.

Cajean-Feroldi C, Nosal F, Nardeux PC, Gallet X, Guymarho J, Baychelier F, Sempé P, Tovey MG, Escary JL, Eid P.

Biochemistry. 2004 Oct 5;43(39):12498-512.

PMID:
15449939
15.

Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation.

Holland JW, Bird S, Williamson B, Woudstra C, Mustafa A, Wang T, Zou J, Blaney SC, Collet B, Secombes CJ.

Mol Immunol. 2008 Dec;46(2):269-85. doi: 10.1016/j.molimm.2008.08.265. Epub 2008 Sep 20.

PMID:
18805586
16.

Identification and expression analysis of cDNAs encoding channel catfish type I interferons.

Long S, Milev-Milovanovic I, Wilson M, Bengten E, Clem LW, Miller NW, Chinchar VG.

Fish Shellfish Immunol. 2006 Jul;21(1):42-59. Epub 2006 Jan 19.

PMID:
16426862
17.

[Anti-viral proteins: from interferon alpha to its receptor].

Chieux V, Hober D, Chehadeh W, Wattr P.

Ann Biol Clin (Paris). 1999 May;57(3):283-90. Review. French.

18.

Differential responsiveness of a splice variant of the human type I interferon receptor to interferons.

Cook JR, Cleary CM, Mariano TM, Izotova L, Pestka S.

J Biol Chem. 1996 Jun 7;271(23):13448-53.

19.

Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells.

Wagner TC, Velichko S, Vogel D, Rani MR, Leung S, Ransohoff RM, Stark GR, Perez HD, Croze E.

J Biol Chem. 2002 Jan 11;277(2):1493-9. Epub 2001 Oct 26.

20.

Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor.

Soh J, Donnelly RJ, Kotenko S, Mariano TM, Cook JR, Wang N, Emanuel S, Schwartz B, Miki T, Pestka S.

Cell. 1994 Mar 11;76(5):793-802.

PMID:
8124716

Supplemental Content

Support Center